Skip to main content

Lanreotide use while Breastfeeding

Drugs containing Lanreotide: Somatuline Depot

Medically reviewed by Drugs.com. Last updated on Apr 23, 2021.

Lanreotide Levels and Effects while Breastfeeding

Summary of Use during Lactation

The excretion of lanreotide into breastmilk has not been studied. However, because it has a high molecular weight of 1096 daltons it is likely to be poorly excreted into breastmilk and it is a peptide that is likely digested in the infant's gastrointestinal tract, so it is unlikely to reach the clinically important levels in infant serum. Lanreotide has been given by injection to newborn infants with congenital hyperinsulinemia; reversible mild elevation of liver enzymes occurred in some infants.[1] The manufacturer states that women should not breastfeed during treatment with depot lanreotide and for 6 months following the last dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Octreotide

Substance Identification

Substance Name

Lanreotide

CAS Registry Number

108736-35-2

Drug Class

  • Breastfeeding
  • Lactation, Hormones
  • Somatostatin Analogs and Derivatives
  • Antineoplastic Agents, Hormonal

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.